Production of anti-retroviral and anti-cancer pharmaceuticals in Russia.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About HETERO

HETERO is a company. HETERO offers products and services including Anti-Retroviral Drugs and Anti-Cancer Drugs.

Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of HETERO

HETERO offers a comprehensive portfolio of products and services, including Anti-Retroviral Drugs and Anti-Cancer Drugs.

Product name locked
Category locked
Primary

Anti-retroviral drugs are manufactured for affordable treatment of viral conditions

Product name locked
Category locked
Locked

Various anti-cancer medications are produced in forms such as tablets and infusions for effective disease management

Funding Insights of HETERO

Premium access

Detailed funding history for HETERO

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by HETERO

Investments
Premium access

Investment portfolio details for HETERO

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - HETERO

Premium access

Detailed financials for HETERO

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Hetero Comparisons

HETERO Primary company
Description
Production of anti-retroviral and anti-cancer pharmaceutical...
Location
-
Founded Year
-
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for HETERO

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of HETERO

Premium access

Detailed competitors of HETERO

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Hetero

Premium access

Complete news archive for HETERO

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about HETERO

HETERO is recognized for its role in manufacturing a wide range of anti-retroviral and anti-cancer drugs at affordable prices, with operations centered in Russia. The primary production site, operated by ООО МАКИЗ-ФАРМА in Moscow, focuses on creating non-sterile forms like tablets and capsules that adhere to global standards. Quality control is handled by independent experts, and collaborations with partners are emphasized to enhance access to effective treatments. Efforts are directed towards building full-cycle production facilities that support modern healthcare needs, ensuring safety and efficacy in all products.

HETERO offers Anti-Retroviral Drugs and Anti-Cancer Drugs.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available